HTGMQ HTG Molecular Diagnostics
- 0.003
- 0.0000.00%
HTG Molecular Diagnostics News
Express News | News On HTG Molecular Diagnostics Inc. (HTGM) Now Under HTGMQ
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersAvalo Therapeutics (NASDAQ:AVTX) shares rose 17.3% to $3.53 during Wednesday's regular session. The company's market cap stands at $46.5 million. Journey Medical (NASDAQ:DERM) shares rose 15.59
Stocks That Hit 52-Week Lows On Wednesday
 On Wednesday, 29 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was NovoCure (NASDAQ:NVCR).Th
Why Are HTG Molecular Diagnostics Shares Plunging Today
MVIS, NVCR and BIG Among Mid-day Movers
HTG Molecular Stock Tanks in Wake of Chapter 11 Bankruptcy Filing
Hoth, Zura Top Healthcare Gainers; HTG Molecular, NovoCure Lead Losers' Pack
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersHoth Therapeutics (NASDAQ:HOTH) shares rose 99.5% to $3.75 during Tuesday's pre-market session. The company's market cap stands at $12.3 million. Novo Integrated Sciences (NASDAQ:NVOS) stock in
TRMD, KOPN and TIO Among Pre-market Losers
12 Health Care Stocks Moving In Monday's Intraday Session
GainersINVO Bioscience (NASDAQ:INVO) stock rose 50.9% to $0.32 during Monday's regular session. Trading volume for this security as of 13:30 EST is 5.4 million, which is 2816.2% of its average full-da
SEV, HTGM and PDSB Among Mid-day Movers
Stocks That Hit 52-Week Lows On Tuesday
 During Tuesday's morning session, 137 companies made new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: Bristol-Myers Squibb (NYSE:BMY) was the biggest company in terms of market c
HTG Molecular Diagnostics Said On May 18, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
HTG Molecular Diagnostics Said On May 18, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
HTG to Highlight the Advantages of Its Drug Discovery Engine at the 2023 BIO International Convention
TUCSON, Ariz., May 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced that its managem
Top Premarket Gainers
Smart for Life (SMFL) shares surged 31% in Wednesday's premarket activity following a 3.3% drop in the previous session. Sunrise New Energy (EPOW) shares rallied 30%, a day after the company reported
HTG Highlights Rhe Advantages Of Its Drug Discovery Engine
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of another technical milestone in its drug discovery bus
HTG Molecular GAAP EPS of -$2.28 Misses by $0.34, Revenue of $1.03M Misses by $0.57M
Express News | HTG Molecular Diagnostics 1Q Rev $1M >HTGM
HTG Molecular Diagnostics 1Q Loss/Shr $2.28 >HTGM
HTG Molecular Diagnostics 1Q Loss/Shr $2.28 >HTGM
Press Release: HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights TUCSON, Ariz., May 10, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM)
Analysis
Price Target
No Data
